KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Diebold Nixdorf (DBD) Cash & Equivalents (2016 - 2026)

Diebold Nixdorf (DBD) has disclosed Cash & Equivalents for 18 consecutive years, with $373.6 million as the latest value for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 16.68% year-over-year to $373.6 million; the TTM value through Mar 2026 reached $373.6 million, up 16.68%, while the annual FY2025 figure was $387.3 million, 24.41% up from the prior year.
  • Cash & Equivalents hit $373.6 million in Q1 2026 for Diebold Nixdorf, down from $387.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $504.6 million in Q2 2023 and bottomed at $128.4 million in Q3 2022.
  • Average Cash & Equivalents over 5 years is $297.8 million, with a median of $280.6 million recorded in 2024.
  • Year-over-year, Cash & Equivalents surged 192.91% in 2023 and then tumbled 45.16% in 2024.
  • Diebold Nixdorf's Cash & Equivalents stood at $319.1 million in 2022, then grew by 17.86% to $376.1 million in 2023, then decreased by 17.23% to $311.3 million in 2024, then grew by 24.41% to $387.3 million in 2025, then fell by 3.54% to $373.6 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $373.6 million, $387.3 million, and $246.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.